Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prapchompoothaweep vs Loratadine in Allergic Rhinitis
NCT03640273Phase 2Completed
- Sponsor
- Thammasat University
- Start
- Nov 2017
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Prapchompoothaweep in allergic rhinitis (AR), sponsored by Thammasat University. Started Nov 2017; status: completed.
02
Drugs
Prapchompoothaweep
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT03640273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03640273.